参考文献
1.
Unemo M, Seifert HS, Hook EW 3rd, Hawkes S, Ndowa F, Dillon JR. Gonorrhoea. Nat Rev Dis
Primers 2019;5:79. doi:10.1038/s41572-019-0128-6.
2.
Japanese Society for Sexually Transmitted Infections Guidelines Preparing Committee
Guidelines for the diagnosis and treatment of STI 2016. Accessed June 29, 2021.
http://jssti.umin.jp/pdf/guideline-2016.pdf
3.
Kirkcaldy RD, Harvey A, Papp JR, Del Rio C, Soge OO, Holmes KK, et al. Neisseria
gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance
Project, 27 Sites, United States, 2014. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002.
2016 Jul 15;65(7):1–19. doi.org/10.15585/mmwr.ss6507a1.
4.
Thakur SD, Araya P, Borthagaray G, Galarza P, Hernandez AL, Payares D, et al. Resistance to
Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South
America and the Caribbean: 2010-2011. Sex Transm Dis. 2017 Mar;44(3):157–60.
doi:10.1097/OLQ.0000000000000587.
5.
Ng L-K, Martin I, Liu G, Bryden L. Mutation in 23S rRNA associated with macrolide resistance
in
Neisseria
gonorrhoeae. Antimicrob Agents
Chemother.
2002
Sep;46(9):3020–5.
doi.org/10.1128/AAC.46.9.3020-3025.2002.
6.
Liu Y-H, Wang Y-H, Liao C-H, Hsueh P-R. Emergence and Spread of Neisseria gonorrhoeae
Strains with High-Level Resistance to Azithromycin in Taiwan from 2001 to 2018. Antimicrob
Agents Chemother. 2019 Sep;63(9):e00773-19. doi:10.1128/AAC.00773-19.
7.
Shimuta K, Lee K, Yasuda M, Furubayashi K, Uchida C, Nakayama S-I, et al. Characterization
of 2 Neisseria gonorrhoeae Strains With High-Level Azithromycin Resistance Isolated in 2015
and
2018
in
Japan.
Sex
Transm
Dis.
2021
Jul
1;48(7):e85–7.
doi.org/10.1097/olq.0000000000001303.
8.
Laumen JGE, Manoharan-Basil SS, Verhoeven E, Abdellati S, De Baetselier I, Crucitti T, et al.
Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae. J
Antimicrob Chemother. 2021 Jun 18;76(7):1752-1758. doi: 10.1093/jac/dkab084.
9.
Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century:
past,
evolution,
and
future.
Clin
Microbiol
Rev.
2014
Jul;27(3):587–613.
doi.org/10.1128/CMR.00010-14.
10. Pham CD, Nash E, Liu H, Schmerer MW, Sharpe S, Woods G, et al. Atypical Mutation in
Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
Antimicrob Agents Chemother. 2021 Jan 20;65(2):e00885-20. doi: 10.1128/AAC.00885-20.
11. Cousin SL, Whittington WLH, Roberts MC. Acquired macrolide resistance genes and the 1 bp
deletion in the mtrR promoter in Neisseria gonorrhoeae. J Antimicrob Chemother. 2003
Jan;51(1):131–3. doi: 10.1093/jac/dkg040.
12. Luna VA, Cousin S, Whittington WL, Roberts MC. Identification of the conjugative mef gene in
clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother.
2000 Sep;44(9):2503–6. doi.org/10.1128/AAC.44.9.2503-2506.2000.
13. Roberts MC, Chung WO, Roe D, Xia M, Marquez C, Borthagaray G, et al. Erythromycinresistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA
methylase
genes.
Antimicrob
Agents
Chemother.
1999
Jun;43(6):1367-72.
doi:
10.1128/AAC.43.6.1367. PMC89280.
14. Martin IMC, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based
identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004
Apr 15;189(8):1497–505. doi.org/10.1086/383047.
15. Unemo M, Dillon J-AR. Review and international recommendation of methods for typing
neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal
epidemiology, treatment, and biology. Clin Microbiol Rev. 2011 Jul;24(3):447–58.
doi:10.1128/CMR.00040-10.
16. Shigemura K, Osawa K, Miura M, Tanaka K, Arakawa S, Shirakawa T, et al. Azithromycin
resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan. Antimicrob
Agents Chemother. 2015 May;59(5):2695–9. doi.org/10.1128/AAC.04320-14.
17. Xue J, Ni C, Zhou H, Zhang C, van der Veen S. Occurrence of high-level azithromycin-resistant
Neisseria gonorrhoeae isolates in China. J Antimicrob Chemother. 2015 Dec;70(12):3404–5.
doi:10.1093/jac/dkv266.
18. Wan C, Li Y, Le W-J, Liu Y-R, Li S, Wang B-X, et al. Increasing Resistance to Azithromycin in
Neisseria gonorrhoeae in Eastern Chinese Cities: Resistance Mechanisms and Genetic Diversity
among Isolates from Nanjing. Antimicrob Agents Chemother. 2018 May;62(5):e02499-17.
doi.org/10.1128/AAC.02499-17.
19. Ohnishi M, Unemo M. Phylogenomics for drug-resistant Neisseria gonorrhoeae. Lancet Infect
Dis. 2014 Mar;14(3):179-80. doi: 10.1016/S1473-3099(13)70700-X.
20. Lee RS, Seemann T, Heffernan H, Kwong JC, Gonçalves da Silva A, Carter GP, et al. Genomic
epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand. J
Antimicrob Chemother. 2018 Feb 1;73(2):353-364. doi:10.1093/jac/dkx405.
21. Yoshimura D, Kajitani R, Gotoh Y, Katahira K, Okuno M, Ogura Y, Hayashi T, Itoh T.
Evaluation of SNP calling methods for closely related bacterial isolates and a novel high-accuracy
pipeline: BactSNP. Microb Genom. 2019 May;5(5):e000261. doi: 10.1099/mgen.0.000261.
22. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR.
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences
using Gubbins. Nucleic Acids Res. 2015 Feb 18;43(3):e15. doi: 10.1093/nar/gku1196.
23. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics.
Bone Marrow Transplant. 2013 Mar;48(3):452-8. doi:10.1038/bmt.2012.244.
24. Yasuda M, Ito S, Kido A, Hamano K, Uchijima Y, Uwatoko N, et al. A single 2 g oral dose of
extended-release azithromycin for treatment of gonococcal urethritis. J Antimicrob Chemother.
2014 Nov;69(11):3116–8. doi:10.1093/jac/dku221.
25. AMR
Clinical
Reference
Center.
Accessed
July
2,
2021.
https://amrcrc.ncgm.go.jp/surveillance/010/20181128172333.html
26. Tanaka M, Furuya R, Irie S, Kanayama A, Kobayashi I. High Prevalence of AzithromycinResistant Neisseria gonorrhoeae Isolates With a Multidrug Resistance Phenotype in Fukuoka,
Japan. Sex Transm Dis. 2015 Jun;42(6):337–41. doi.org/10.1097/OLQ.0000000000000279.
27. Takayama Y, Nakayama S, Shimuta K, Morita-Ishihara T, Ohnishi M. Characterization of
azithromycin-resistant Neisseria gonorrhoeae isolated in Tokyo in 2005-2011. J Infect
Chemother
Off
Jpn
Soc
Chemother.
2014
May;20(5):339–41.
doi.org/10.1016/j.jiac.2014.01.007.
28. Cole MJ, Spiteri G, Jacobsson S, Woodford N, Tripodo F, Amato-Gauci AJ, et al. Overall Low
Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria
gonorrhoeae in 24 European Countries, 2015. BMC Infect Dis. 2017 Sep 11;17(1):617.
doi.org/10.1186/s12879-017-2707-z.
29. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria
gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents
Chemother. 2010 Sep;54(9):3812–6. doi.org/10.1128/AAC.00309-10.
30. Demczuk W, Martin I, Peterson S, Bharat A, Van Domselaar G, Graham M, et al. Genomic
Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria
gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol. 2016 May;54(5):1304–13.
doi.org/10.1128/JCM.03195-15.
31. Calado J, Castro R, Lopes Â, Campos MJ, Rocha M, et al. Antimicrobial resistance and molecular
characteristics of Neisseria gonorrhoeae isolates from men who have sex with men. Int J Infect
Dis. 2019 Feb;79:116-122. doi: 10.1016/j.ijid.2018.10.030.
32. Maduna LD, Kock MM, van der Veer BMJW, Radebe O, McIntyre J, van Alphen LB, et al.
Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in
Johannesburg, South Africa. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e00906-20. doi:
10.1128/AAC.00906-20.
33. Beggs GA, Ayala JC, Kavanaugh LG, Read TD, Hooks GM, Schumacher MA, et al. Structures
of Neisseria gonorrhoeae MtrR-operator complexes reveal molecular mechanisms of DNA
recognition and antibiotic resistance-conferring clinical mutations. Nucleic Acids Res. 2021 Apr
19;49(7):4155-4170.doi: 10.1093/nar/gkab213.
34. Unemo M, Dillon JA. Review and international recommendation of methods for typing neisseria
gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology,
treatment, and biology. Clin Microbiol Rev. 2011 Jul;24(3):447-58. doi: 10.1128/CMR.00040-10.
35. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and
untreatable gonorrhea. Future Microbiol. 2012 Dec;7(12):1401-22. doi: 10.2217/fmb.12.117.
36. Golparian D, Hellmark B, Fredlund H, Unemo M. Emergence, spread and characteristics of
Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-
spectrum cephalosporins in Sweden. Sex Transm Infect. 2010 Nov;86(6):454–60.
doi:10.1136/sti.2010.045377.
37. Tanaka M, Koga Y, Nakayama H, Kanayama A, Kobayashi I, Saika T, et al. Antibiotic-resistant
phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain
clusters with multidrug-resistant phenotypes. Sex Transm Dis. 2011 Sep;38(9):871–5.
doi:10.1097/OLQ.0b013e31821d0f98.
38. Shimuta K, Unemo M, Nakayama S-I, Morita-Ishihara T, Dorin M, Kawahata T, et al.
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and
Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041)
with high-level ceftriaxone resistance. Antimicrob Agents Chemother. 2013 Nov;57(11):5225–
32. doi.org/10.1128/AAC.01295-13.
39. Zheng Z, Liu L, Shen X, Yu J, Chen L, Zhan L, et al. Antimicrobial Resistance And Molecular
Characteristics Among Neisseria gonorrhoeae Clinical Isolates In A Chinese Tertiary Hospital.
Infect Drug Resist. 2019 Oct;12:3301-3309. doi: 10.2147/IDR.S221109.
...